Details for New Drug Application (NDA): 022173
✉ Email this page to a colleague
The generic ingredient in ZYPREXA RELPREVV is olanzapine pamoate. There are thirty-three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the olanzapine pamoate profile page.
Summary for 022173
Tradename: | ZYPREXA RELPREVV |
Applicant: | Cheplapharm |
Ingredient: | olanzapine pamoate |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Suppliers and Packaging for NDA: 022173
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ZYPREXA RELPREVV | olanzapine pamoate | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 022173 | NDA | Eli Lilly and Company | 0002-7635 | 0002-7635-11 | 1 KIT in 1 CARTON (0002-7635-11) * 1.4 mL in 1 VIAL (0002-7658-01) * 3 mL in 1 VIAL (0002-7622-01) |
ZYPREXA RELPREVV | olanzapine pamoate | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 022173 | NDA | Eli Lilly and Company | 0002-7636 | 0002-7636-11 | 1 KIT in 1 CARTON (0002-7636-11) * 2 mL in 1 VIAL (0002-7659-01) * 3 mL in 1 VIAL (0002-7622-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | Strength | EQ 210MG BASE/VIAL | ||||
Approval Date: | Dec 11, 2009 | TE: | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | Strength | EQ 300MG BASE/VIAL | ||||
Approval Date: | Dec 11, 2009 | TE: | RLD: | Yes |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | Strength | EQ 405MG BASE/VIAL | ||||
Approval Date: | Dec 11, 2009 | TE: | RLD: | Yes |
Expired US Patents for NDA 022173
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Cheplapharm | ZYPREXA RELPREVV | olanzapine pamoate | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 022173-003 | Dec 11, 2009 | ⤷ Sign Up | ⤷ Sign Up |
Cheplapharm | ZYPREXA RELPREVV | olanzapine pamoate | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 022173-001 | Dec 11, 2009 | ⤷ Sign Up | ⤷ Sign Up |
Cheplapharm | ZYPREXA RELPREVV | olanzapine pamoate | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 022173-002 | Dec 11, 2009 | ⤷ Sign Up | ⤷ Sign Up |
Cheplapharm | ZYPREXA RELPREVV | olanzapine pamoate | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 022173-001 | Dec 11, 2009 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription